ID   Mel Kor-TurboRFP
AC   CVCL_B6KK
SY   mel Kor-TurboRFP
DR   cancercelllines; CVCL_B6KK
DR   Wikidata; Q112129280
RX   DOI=10.1134/S1070363215010429;
RX   Patent=RU2458123;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 730D.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Transfected with: UniProtKB; H3JQU7; Entacmaea quadricolor red fluorescent protein eqFP578 (mutated to obtain TurboRFP).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6KB ! Mel Kor
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   DOI=10.1134/S1070363215010429;
RA   Meerovich I.G., Kazachkina N.I., Savitsky A.P.;
RT   "Investigation of the effect of photosensitizer Tiosense on the tumor
RT   model mel Kor-TurboRFP expressed red fluorescent protein.";
RL   Russ. J. Gen. Chem. 85:274-279(2015).
//
RX   Patent=RU2458123;
RA   Meerovich I.G., Zherdeva V.V., Arslanbaeva L.R., Savitsky A.P.,
RA   Burova O.S., Mikhailova I.N., Morozova L.F., Baryshnikov A.Y.;
RT   "Fluorescent cell line mel Kor-TurboRFP and method for using it for in
RT   vitro studies in experimental oncology.";
RL   Patent number RU2458123, 10-Aug-2012.
//